Pelthos Therapeutics Inc. (PTHS) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Feb 3Feb 6Feb 11Feb 17Feb 20Feb 25Mar 3Mar 6

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

—

Market Cap

—

MomentumView details →

1D Return

—

YTD Return

—

RSI (14)

—

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

—

Market Cap

—

RSI (14)

—

MomentumView details →

1D Return

—

YTD Return

—

ProfitabilityView details →

Gross Margin

—

Net Margin

—

EBITDA Margin

—

ROE (TTM)

—

ROA (TTM)

—

Asset Turnover

—

GrowthView details →

Revenue YoY

—

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

—

EPS CAGR 3Y

—

EBITDA YoY

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

—

Current Ratio

—

Quick Ratio

—

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

7.41M

Net Income (TTM)

−23.58M

Op. CF (TTM)

−17.01M

Latest newsMore news →

Matthew Pauls was appointed as a Class I director of Palvella Therapeutics, Inc.68d ago

Latest newsMore news →

Matthew Pauls was appointed as a Class I director of Palvella Therapeutics, Inc.68d ago